Kartik Bhatia | Medicine and Dentistry | Research Excellence Award

Published on by World Top Scientists

Assoc. Prof. Dr. Kartik Bhatia | Medicine and Dentistry | Research Excellence Award 

Clinical Associate Professor | University of Sydney | Australia

Associate Professor Dr. Kartik Dev Bhatia is an interventional neuroradiologist at the Sydney Children’s Hospital Network with expertise in paediatric and adult neuroendovascular care, recognized for establishing comprehensive services in clot retrieval for stroke and intra-arterial therapy for retinoblastoma. He holds a PhD and advanced clinical qualifications including subspecialty recognition in interventional neuroradiology, fellowship of the Royal Australian and New Zealand College of Radiologists, and dual medical and surgical degrees, underpinning a strong academic and clinical foundation. His professional experience spans leadership of multidisciplinary cerebrovascular programs, major fellowships across leading Australian and international centres, and service as a staff specialist and consultant interventional neuroradiologist across multiple tertiary hospitals. Dr. Bhatia’s research focuses on paediatric neurointervention, stroke, vascular malformations, and innovative endovascular therapies, with influential publications in high-impact journals and contributions to key international registries. He has authored multiple book chapters and serves as a reviewer for prominent journals in neuroradiology, neurology, and stroke medicine, reflecting his standing in the academic community. His work has advanced understanding of paediatric cerebrovascular disease, liquid biopsy applications in vascular malformations, and endovascular treatment paradigms. A recipient of distinctions including a Research Excellence Award, he also contributes through editorial activities, scholarly mentorship, and active membership in multidisciplinary and professional bodies. Dr. Bhatia’s blend of clinical innovation, academic leadership, and sustained research impact positions him as an outstanding candidate for recognition.

Citation Metrics (Google Scholar)

1500
1000
500
0

1409
Citations

22
h-index

30
i10-index


View Google Scholar Profile

Top Publications

Feyera Gemeda | Infectious Diseases | Outstanding Scientist Award

Published on by World Top Scientists

Assoc. Prof. Dr. Feyera Gemeda | Infectious Diseases | Outstanding Scientist Award

Associate Professor | Dima Jimma university | Ethiopia

Assoc. Prof. Dr. Feyera Gemeda Dima is a distinguished researcher and academic with extensive experience in Infectious Diseases, Medical Mycology, and Medicine. He has demonstrated excellence in teaching, research, and mentorship at both national and international levels, fostering the development of students and early-career researchers. His work emphasizes innovation in scientific research, editorial contributions, and leadership in grant assessment and curriculum development. He has contributed significantly to global collaborations and serves as a Chief Scientist and Global Assessor, reflecting his commitment to advancing scientific knowledge. His research focuses on improving understanding and management of infectious diseases, with the potential to influence public health strategies. Prof. Gemeda’s dedication to integrating innovative approaches and interdisciplinary perspectives underscores his capacity for impactful contributions in the field.

Profile:  Google Scholar

Featured Publications

1. T. Gizaw and F. G. Dima, “Assessment of problems and constraints associated with artificial insemination service in the two selected districts of Arsi zone,” Journal of Harmonized Research in Medical and Health Sciences, vol. 3, no. 1, pp. 14–37, 2016.

2. A. Edao, F. G. Dima, and F. B. Deressa, “Prevalence of bovine cysticercosis and status of human taeniasis in and around Asella town, Tiyoworeda, south east Ethiopia,” Glob J Med Res, vol. 16, pp. 18–26, 2016.

3. F. Gemeda, “Prevalence of bovine Trypanosomosis in and around Nekemte areas, east Wollega zone, Ethiopia,” Open Access Library Journal, vol. 2, no. 05, p. 1, 2015.

4. D. T. Legesse and F. Gemeda, “Comparison of two parasitological tests and post mortem examination to detect prevalence of bovine fasciolosis at Ambo Town Municipal Abattoir, West Shewa Zone, Ethiopia,” Open Access Library Journal, vol. 2, no. 8, pp. 1–5, 2015.

5. F. G. Dima and T. Fikedu, “Review on infectious bovine keratoconjunctivitis,” J Bacteriol Infect Dis, vol. 4, no. 4, pp. 1–6, 2021.

Dr. Gemeda’s work advances the understanding and control of infectious diseases, providing evidence-driven insights that strengthen public health systems and guide global disease management strategies.

Milad Shirvaliloo | Cancer Epigenetics | Best Researcher Award 

Published on by World Top Scientists

Dr. Milad Shirvaliloo | Cancer Epigenetics | Best Researcher Award 

Research Associate | Iran University of Medical Sciences | Iran

Dr. Milad Shirvaliloo is an accomplished physician–researcher specializing in epigenetics with a focus on cancer and pulmonary medicine. Holding a Doctor of Medicine and a Master of Business Administration in Health Sciences, he combines clinical expertise with research innovation to advance precision medicine. As a Postgraduate Researcher at the Finetech in Medicine Research Center, he leads studies on nanoparticle-based therapeutic interventions and their effects on histone acetylation in cancer. Dr. Shirvaliloo has authored more than forty peer-reviewed publications and a book chapter, contributing extensively to understanding molecular and epigenetic mechanisms in disease pathogenesis. His scholarly output includes first-author and single-author papers in leading journals, where he explores the roles of histone modifications, long noncoding RNAs, and nanobiosensor technologies in diagnostics and therapeutics. He has demonstrated academic leadership as an Editorial Board Member for Epigenomics and Molecular and Cellular Biochemistry and has served as a peer reviewer for over sixty high-impact journals. Recognized for his scientific excellence and editorial contributions, he has received the Best Researcher Award for his outstanding achievements in biomedical science. His ongoing work reflects a strong commitment to translational research, interdisciplinary collaboration, and mentorship of emerging scientists. With a clear vision for integrating molecular biology, nanotechnology, and clinical application, Dr. Shirvaliloo exemplifies the future of innovative medical research and continues to make significant contributions to global health advancement.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Heris, R. M., Shirvaliloo, M., Abbaspour-Aghdam, S., Hazrati, A., Shariati, A., & others. (2022). The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment. Stem Cell Research & Therapy, 13(1), 371.

2. Sheervalilou, R., Shirvaliloo, M., Dadashzadeh, N., Shirvalilou, S., Shahraki, O., & others. (2020). COVID‐19 under spotlight: A close look at the origin, transmission, diagnosis, and treatment of the 2019‐nCoV disease. Journal of Cellular Physiology, 235(12), 8873–8924.

3. Aghbash, P. S., Eslami, N., Shirvaliloo, M., & Baghi, H. B. (2021). Viral coinfections in COVID‐19. Journal of Medical Virology, 93(9), 5310–5322.

4. Shirvalilou, S., Khoei, S., Esfahani, A. J., Kamali, M., Shirvaliloo, M., & others. (2021). Magnetic hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: A systematic review. Journal of Neuro-Oncology, 152(3), 419–428.

5. Razlansari, M., Jafarinejad, S., Rahdar, A., Shirvaliloo, M., Arshad, R., & others. (2023). Development and classification of RNA aptamers for therapeutic purposes: An updated review with emphasis on cancer. Molecular and Cellular Biochemistry, 478(7), 1573–1598.*

Dr. Milad Shirvaliloo’s pioneering research in epigenetics and nanomedicine bridges molecular science with clinical application, driving innovations in cancer and pulmonary disease diagnostics and therapies. His work advances precision medicine and fosters global scientific collaboration, contributing to more effective, personalized healthcare solutions.

Maria Morales-Suarez-Varela | Medicine and Pharmacy | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Maria Morales-Suarez-Varela | Medicine and Pharmacy | Best Researcher Award
Full professor | University of Valencia | Spain

Prof. Dr. Maria Morales-Suárez-Varela is a distinguished academic and researcher specializing in public health, preventive medicine, nutrition, and environmental epidemiology. Serving as a Full Professor at the Universitat de València, she has made outstanding contributions to advancing scientific understanding of the relationships between environmental exposures, nutrition, and population health. She holds a Doctorate and a Licentiate in Medicine and Surgery, with advanced expertise in preventive and public health sciences. As Principal Investigator of prominent research groups within the CIBER of Epidemiology and Public Health and the Universitat de València, she has led numerous national and international projects funded by competitive public and private agencies. Her scholarly impact is reflected in hundreds of high-quality publications indexed in leading databases, an extensive record of citations, and a strong h-index that underscores her scientific influence. She has supervised numerous doctoral theses and has presented extensively at global conferences. Her research integrates epidemiological evidence with policy-relevant health solutions, with special focus on maternal and child health, dietary patterns, environmental risks, and population well-being. Recognized for her leadership and excellence, she has received multiple distinctions for research merit and contributes actively to scientific networks, editorial boards, and peer-review committees. Prof. Morales-Suárez-Varela exemplifies academic rigor, innovation, and dedication to public health advancement, making her a highly deserving candidate for this award.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Morales-Suárez-Varela, M., et al. (2025). Effect of the Mediterranean diet on BMI and body composition: A preliminary pre-post intervention study in pediatric overweight patients. Nutrition.

2. Morales-Suárez-Varela, M., et al. (2025). Long-term prognostic implications of type 2 diabetes mellitus in colorectal cancer patients. Colorectal Disease.

3. Morales-Suárez-Varela, M., et al. (2025). Systematic review of prenatal exposure to PM2.5 and its chemical components and their effects on neurodevelopmental outcomes in neonates.

4. Morales-Suárez-Varela, M., et al. (2025). Helminth/Protozoan coinfections in chronic fascioliasis cases in human hyperendemic areas: High risk of multiparasitism linked to transmission aspects and immunological, environmental and social factors. Tropical Medicine and Infectious Disease.

5. Morales-Suárez-Varela, M., et al. (2025). Analysis of demographic and health characteristics and adherence to the Mediterranean diet in pregnant women: MEDAS questionnaire. Semergen.

Prof. Dr. Maria Morales-Suárez-Varela’s research advances global understanding of how environmental, nutritional, and lifestyle factors influence public health outcomes. Her work bridges science and policy, driving innovations that promote healthier populations, sustainable healthcare practices, and evidence-based prevention strategies worldwide.

Na Eun Lee | Extracellular Vesicles | Best Researcher Award

Published on by World Top Scientists

Ms. Na Eun Lee | Extracellular Vesicles | Best Researcher Award

Senior Research Scientist | Sungkyunkwan University | South Korea

Ms. Na Eun Lee, Ph.D. Candidate at the Department of Health Sciences and Technology (SAIHST), Sungkyunkwan University, is an accomplished researcher specializing in regenerative medicine, stem cell biology, and translational health sciences. She holds a Master’s degree in Health Sciences and Technology from Sungkyunkwan University and a Bachelor’s degree in Applied Biochemistry from Konkuk University. Currently pursuing her doctoral studies, she integrates molecular and cellular approaches to advance extracellular vesicle-based therapeutics and skin rejuvenation technologies. Throughout her professional career, Ms. Lee has held senior scientific and leadership positions at prominent biomedical companies and research institutions, where she directed projects in cell therapy development, angiogenesis research, and clinical translation. Her scholarly contributions include publications in high-impact journals such as Cytotherapy, Biochemical and Biophysical Research Communications, and the International Journal of Molecular Sciences, highlighting innovations in mesenchymal stromal cell biology and nano-encapsulation delivery systems. Renowned for her expertise in extracellular vesicle analysis, molecular diagnostics, and regenerative research, Ms. Lee’s work bridges fundamental science and clinical application. She has been recognized for her research excellence and leadership in biomedical innovation, contributing actively to the advancement of stem cell-based therapeutic strategies and representing a distinguished example of scientific dedication and translational impact in the field of health sciences and technology.

Profiles: ORCID

Featured Publications

1 S. J. Yang, J. K. Son, S. J. Hong, N. E. Lee, D. Y. Shin, S. H. Park, S. B. An, Y. C. Sung, J. B. Park, and H. M. Yang, et al., “Ectopic vascularized bone formation by human umbilical cord-derived mesenchymal stromal cells expressing bone morphogenetic factor-2 and endothelial cells,” Biochemical and Biophysical Research Communications.

2 N. E. Lee, S. J. Kim, S. J. Yang, S. Y. Joo, H. Park, K. W. Lee, H. M. Yang, and J. B. Park, “Comparative characterization of mesenchymal stromal cells from multiple abdominal adipose tissues and enrichment of angiogenic ability via CD146 molecule,” Cytotherapy.

3 H. M. Yang, H. J. Choi, D. P. Hong, S. Y. Joo, N. E. Lee, J. Y. Song, Y. L. Choi, J. Lee, D. Choi, B. Kim, et al., “The analysis of mutations and exon deletions at TSC2 gene in angiomyolipomas associated with tuberous sclerosis complex,” Experimental and Molecular Pathology.

Aneta Guzek | Bloodstream Infections | Best Researcher Award

Published on by World Top Scientists

Dr. Aneta Guzek | Bloodstream Infections | Best Researcher Award

Head of Microbial Laboratory | National Research Institute | Poland

Dr. Aneta Guzek is the Head of the Microbiology Laboratory at the Military Institute of Medicine – National Research Institute in Warsaw, Poland, specializing in medical microbiology and laboratory diagnostics. She holds a PhD in medicine with a specialization in medical microbiology from the Military Institute of Medicine, complemented by postgraduate qualifications in medical microbiology from the Medical University of Lublin and innovation management in the health care sector from Kozminski University. Additionally, she earned an MSc in biology with a focus on microbiology from the University of Warsaw and is a certified laboratory diagnostician. Dr. Guzek leads a multidisciplinary team overseeing comprehensive microbiological diagnostics, implementation of advanced diagnostic methods, and the development of institutional policies on infection control and antibiotic stewardship. Her research contributions include studies on antimicrobial resistance, hospital infection control, and the advancement of microbiological procedures, with numerous publications and citations in recognized scientific sources. She collaborates with national and reference laboratories, contributing to public health and medical innovation. Her exemplary service has been recognized with prestigious honors, including the first place in the Hippocrates Medical Poll for Laboratory Diagnostician of the Year and the Badge of Honour from the Military Medical Institute for her efforts during the COVID-19 pandemic. Dr. Guzek also holds certification in Good Clinical Practice (ICH E6 R2), underscoring her commitment to excellence in research and clinical integrity.

Profiles: Scopus | ORCID

Featured Publications

1. Guzek, A., et al. (2025). Microbiological comparison of maxillary sinus rinses in non-odontogenic and odontogenic sinusitis of primarily endodontic origin. Journal of Clinical Medicine.

2. Guzek, A., et al. (2024). Outcomes of 23 patients diagnosed with New Delhi metallo-beta-lactamase (NDM)-producing Klebsiella pneumoniae infection treated with ceftazidime/avibactam and aztreonam at a single center in Poland. Journal of Clinical Medicine.

3. Guzek, A., et al. (2024). Dissemination of extensively drug-resistant NDM-producing Providencia stuartii in Europe linked to patients transferred from Ukraine, March 2022 to March 2023. Eurosurveillance.

Judita Kinkorova | Biobanking | Best Researcher Award 

Published on by World Top Scientists

Assoc. Prof. Dr. Judita Kinkorova | Biobanking | Best Researcher Award 

Senior Scientist | University Hospital in Pilsen | Czech Republic

Assoc. Prof. Dr. Judita Kinkorová is a leading researcher in biobanking, personalized medicine, and preventive healthcare, recognized for her significant contributions to international research collaboration. She has successfully coordinated major European research initiatives, including FP7 and Horizon 2020 projects, and has played a pivotal role in developing hospital-integrated biobanks that strengthen biomedical research infrastructure. Her active participation in scientific societies and editorial boards reflects her influence and thought leadership in advancing precision health. Dr. Kinkorová’s work integrates scientific rigor with strategic collaboration, mentorship, and policy engagement, demonstrating strong potential for further innovation in genomic and biomarker research, sustainable biobanking, and cross-border scientific partnerships. Her research output is substantial, comprising 47 Scopus-indexed publications, cited 852 times by 744 documents, with an h-index of 12, highlighting the measurable impact and quality of her contributions to the field.

Profile: Scopus | ORCID

Featured Publications

1. J. Kinkorová and O. Topolčan, “Biobanks in the era of big data: objectives, challenges, perspectives, and innovations for predictive, preventive, and personalised medicine,” EPMA Journal, 2020.

2. J. Kinkorová, O. Topolčan, and R. Kučera, “Informed Consent in the Newly Established Biobank,” International Journal of Environmental Research and Public Health, 2019.

3. J. Kinkorová and O. Topolčan, “Biobanks in Horizon 2020: sustainability and attractive perspectives,” EPMA Journal, 2018.

4. “The 44th Congress of the International Society of Oncology and Biomarkers: Rio de Janeiro, Brazil, 7-10 September 2017,” Future Medicine, 2018.

5. J. Kinkorová and O. Topolčan, “Biobanks – European infrastructur | Biobanky – Evropská infrastruktura,” Casopis Lekaru Ceskych, 2016.

Hans-Werner Denker | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Hans-Werner Denker | Medicine and Dentistry | Best Researcher Award

University Professor at Universität Duisburg-Essen, Germany

Prof. Dr. Hans-Werner Denker is a distinguished scientist whose pioneering work has significantly advanced the fields of developmental biology, reproductive biology, and stem cell research. His studies have provided deep insights into embryonic development, cell differentiation, trophoblast-endometrial interactions, and implantation biology, establishing him as a leading authority in reproductive sciences. He has also contributed extensively to stem cell biology, focusing on pluripotency, embryoid formation, and the ethical dimensions of stem cell research, which has global scientific and societal importance. As Head of Anatomy and Developmental Biology at a major university, he demonstrated exceptional leadership, mentoring, and academic vision. His editorial stewardship of an international journal for more than two decades further highlights his influence in shaping scientific discourse worldwide. Through interdisciplinary collaborations and innovative approaches, including the use of 3D model systems, Prof. Denker has left a lasting impact, making him a highly respected and influential figure in biomedical research.

Professional Profile 

Scopus Profile | ORCID Profile 

Education

Prof. Dr. Hans-Werner Denker pursued a comprehensive academic path that combined medicine and zoology, laying a strong interdisciplinary foundation for his career. He studied medicine at the University of Hamburg and the University of Marburg, completing his medical state examination and licensure, followed by his M.D. with a dissertation on enzymatic topochemistry during early rabbit embryonic development. Simultaneously, he studied zoology at the University of Marburg, earning a Ph.D. focused on carbohydrate chemistry in early implantation processes. This dual training in both medicine and natural sciences provided him with a unique perspective on developmental biology and reproductive sciences. In 1976, he achieved his Habilitation at RWTH Aachen University, gaining the venia legendi in anatomy and reproductive biology, which marked the formal recognition of his ability to independently conduct advanced research and teaching. His diverse academic background equipped him with the tools to address complex biological questions at multiple levels.

Experience

Prof. Dr. Hans-Werner Denker’s professional journey reflects decades of excellence in academic leadership, research, and international collaboration. He began his career as a scientific assistant and later senior assistant at the Max Planck Institute for Immunobiology in Freiburg. His international outlook was shaped by visiting scientist roles in the United States, including Wayne State University in Detroit and the University of California at Davis. He subsequently served as Assistant Professor and later full Professor at RWTH Aachen University, where he headed the Division of Anatomy and Reproductive Biology. In 1989, he was appointed Chair and Head of the Institute of Anatomy at the University of Duisburg-Essen, a position he held until his retirement. Throughout his career, he guided both research and education, establishing new directions in anatomy, developmental biology, and reproductive sciences. His leadership extended beyond institutions to the broader scientific community, shaping research agendas at the international level.

Research Focus

Prof. Dr. Hans-Werner Denker’s research spans developmental biology, reproductive biology, and stem cell science, with an emphasis on the earliest stages of mammalian life. He investigated the processes of cleavage, blastocyst formation, and cell differentiation, particularly focusing on trophoblast and embryoblast development. His pioneering work in embryo implantation examined cell-cell and cell-matrix interactions, epithelial-mesenchymal transitions, and the role of adhesion molecules and proteinases. He developed innovative model systems, such as 3D trophoblast spheroids and endometrial cultures, which became valuable tools for studying implantation and tumor invasion. In stem cell biology, he explored pluripotency, totipotency, embryoid formation, and ethical questions surrounding stem cell research. His studies bridged fundamental biology with applied biomedical challenges, providing insights relevant to infertility, regenerative medicine, and cancer biology. By integrating developmental biology with bioethics, he addressed not only scientific but also societal implications, making his research influential across multiple domains.

Award and Honor

Prof. Dr. Hans-Werner Denker has earned wide recognition for his lifelong contributions to science, academia, and ethical discourse in biology. While his most visible honor is his long tenure as Editor-in-Chief of the prestigious international journal Acta Anatomica (later Cells Tissues Organs), where he influenced global scholarship for over two decades, his reputation is equally reflected in memberships across leading scientific societies. He has been an active member of organizations such as the Society for the Study of Reproduction, the German Society for Cell Biology, and the European Tissue Engineering Society. His expertise was sought in interdisciplinary networks like the Competence Network for Stem Cell Research in North Rhine-Westphalia, underscoring his role in advancing both research and policy. Although specific awards are not detailed in the provided record, his leadership roles, editorship, and international collaborations serve as strong evidence of the recognition and respect he has earned within the scientific community.

Publication Top Notes

  • Title: Embryoids, models, embryos? We need to take a new look at legal norms concerning the beginning of organismic development
    Authors: Hans-Werner Denker
    Year: 2023
    Citations: 3

  • Title: Stem Cell-Derived Organoids, Embryoids, and Embryos: Advances in Organismic Development In Vitro Force Us to Re-Focus on Ethical and Legal Aspects of Model Choice
    Authors: Hans-Werner Denker
    Year: 2023

  • Title: Autonomy in the Development of Stem Cell-Derived Embryoids: Sprouting Blastocyst-Like Cysts, and Ethical Implications
    Authors: Hans-Werner Denker
    Year: 2021
    Citations: 17

Conclusion

In conclusion, Prof. Dr. Hans-Werner Denker’s publications highlight a career deeply committed to advancing developmental biology, reproductive science, and stem cell research, while simultaneously addressing the ethical and legal implications of these fields. His recent works on embryoids, organoids, and embryonic self-organization underscore both his scientific depth and his engagement with societal concerns. With strong citation impact and international recognition, his research continues to influence scientific understanding, ethical debates, and biomedical policy. Overall, his body of work demonstrates the qualities of a visionary researcher whose contributions extend far beyond laboratory findings, making him an exemplary candidate for recognition and awards in research excellence.

Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Published on by World Top Scientists

Dr. Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Doctor at Medical University, Varna, Bulgaria

Dr. Yoana Dyankova Dyankova is a dedicated pediatrician and clinical researcher specializing in pediatric gastroenterology, hepatology, and nutrition. She holds a PhD in Pediatrics from the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, where she also serves in the Pediatric Intensive Care Unit at St. Marina University Hospital. Her research focuses primarily on celiac disease in children, particularly its impact on bone health, as demonstrated in her dissertation and multiple peer-reviewed publications, including a recent article in Nutrients (2025). Dr. Dyankova is an active member of national pediatric and gastroenterology associations and contributes to both clinical care and academic development. Fluent in English and German, she engages with the international scientific community and remains committed to translating research into improved patient outcomes. With her growing publication record, clinical integration, and academic rigor, she stands out as a promising young researcher in the field of pediatric medicine.

Professional Profile 

Google Scholar
ORCID Profile 

Education

Dr. Yoana Dyankova Dyankova began her academic journey at the Vasil Drumev High School of Natural Sciences and Mathematics in Veliko Tarnovo, graduating in 2010. She pursued her medical degree at the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, completing it in 2016. From 2017 to 2022, she specialized in pediatrics, gaining comprehensive clinical training and board certification in the field. In 2018, she enrolled in a PhD program in Pediatrics at the same university, where she focused her research on celiac disease and its effects on pediatric bone health. She successfully defended her dissertation in 2023. Dr. Dyankova has since continued to develop professionally by pursuing further specialization in pediatric gastroenterology starting in July 2025. Her academic path demonstrates strong commitment, discipline, and a focused interest in improving pediatric healthcare through both clinical practice and rigorous scientific research.

Professional Experience

Dr. Dyankova has cultivated a balanced career combining clinical excellence and academic growth. Since January 2022, she has served as a pediatrician at the Pediatric Intensive Care Unit (PICU) of the First Children’s Clinic, St. Marina University Hospital in Varna. Her role in the PICU places her at the frontline of managing critically ill children, often requiring advanced decision-making and teamwork in high-pressure situations. Prior to this, she completed a five-year pediatric residency, gaining hands-on experience in general pediatrics. Her transition into the subspecialty of pediatric gastroenterology as of July 2025 marks a strategic shift aligned with her research interests. Parallel to her clinical duties, Dr. Dyankova was engaged in doctoral studies for five years, conducting original research and contributing to academic publications. Her dual role as both a clinician and researcher enhances her ability to apply scientific findings directly to patient care, making her a valuable asset in modern pediatric medicine.

Research Interest

Dr. Dyankova’s primary research interests lie at the intersection of pediatric gastroenterology, hepatology, and nutrition, with a concentrated focus on celiac disease (CD). Her doctoral thesis explored bone health in children with CD, addressing the metabolic and developmental complications arising from malabsorption and chronic inflammation. Beyond celiac disease, she has expressed research interest in related gastrointestinal disorders such as inflammatory bowel disease (IBD), as well as broader issues within pediatric intensive care. Her work is characterized by clinical relevance and translational value, aiming to bridge the gap between scientific research and bedside care. Publications in both national and international journals reflect her dedication to improving diagnostic and treatment protocols in children with chronic gastrointestinal conditions. Dr. Dyankova continues to build her research portfolio by participating in collaborative studies, focusing on early diagnosis, nutritional interventions, and long-term management outcomes in affected pediatric populations, ensuring a direct impact on clinical practice.

Award and Honor

While specific named awards are not listed in the biography, Dr. Yoana Dyankova Dyankova has received notable academic and professional recognition through her successful completion of a PhD and multiple scientific publications. Her research has been published in reputable journals such as Nutrients, indicating peer validation and relevance of her work. She is an active member of the National Pediatric Association and the community of Pediatric Gastroenterologists in Bulgaria, reflecting her standing in the professional community. These memberships signify not only recognition by peers but also her continued contribution to scientific discussions and advancements in pediatric healthcare. Her role in high-stakes clinical environments like the Pediatric Intensive Care Unit further demonstrates trust in her medical competence and decision-making. With growing academic output and clear specialization in a crucial field, Dr. Dyankova is well-positioned to earn future distinctions and leadership roles in pediatric research and clinical practice at both national and international levels.

Conclusion

Dr. Yoana Dyankova Dyankova exemplifies the qualities of a dedicated clinician-scientist, balancing hands-on pediatric care with high-impact academic research. With a solid foundation in pediatrics and a focused interest in gastroenterology and nutrition, she has steadily advanced her career through both clinical excellence and scholarly contribution. Her doctoral work on bone health in children with celiac disease highlights her ability to address complex, real-world health challenges through evidence-based research. Now working in a pediatric intensive care setting and continuing her subspecialty training, Dr. Dyankova is expanding her expertise and influence in critical areas of child health. Her publications, professional affiliations, and academic achievements underscore a deep commitment to the advancement of pediatric medicine. While still early in her career, her trajectory suggests strong potential for leadership in research and healthcare. She is a promising candidate for recognition such as the Best Researcher Award and is well-poised for continued professional impact.

Publications Top Notes

  1. Title: Presentation of Childhood Newly-Diagnosed Diabetes During the COVID-19 Pandemic – Is There a Change?

    • Authors: Y. Bazdarska, V. Iotova, T. Karamfilova, Y. Dyankova, T. Stefanova, …

    • Journal: Diabetes Technology & Therapeutics, Vol. 23, A202

    • Year: 2021

  1. Title: Delayed Bone Age and Osteoprotegerin Levels in Pediatric Celiac Disease: A Three-Year Case–Control Study

    • Authors: R. Pancheva, Y. Dyankova, N. Rasheva, K. Koleva, V. Iotova, M. Dzhogova, M. Fiore, M. Georgieva

    • Journal: Nutrients, Vol. 17 (14), Article 2295

    • Year: 2025

  1. Title: Macrophage Activation Syndrome After COVID-19 Infection in a Patient with Systemic Juvenile Idiopathic Arthritis

    • Authors: M. Boyadzhiev, B. Varbanova, M. Belcheva, P. Shivachev, D. Krumova, Y. Dyankova, …

    • Journal: Scripta Scientifica Medica, Vol. 55(1), pp. 27–31

    • Year: 2023

  1. Title: Bone Health in Children with Celiac Disease (PhD Dissertation)

    • Author: Y. Dyankova

    • Database: PQDT-Global (ProQuest Dissertations)

    • Year: 2022

  1. Title: New Developments in the Diagnostics of Celiac Disease in Children

    • Authors: Y. Dyankova, M. Georgieva, N. Rasheva, K. Koleva

    • Journal: Journal of the Union of Scientists-Varna. Medicine and Ecology Series, Vol. 24(1)

    • Year: 2019

  1. Title: Bacterial Pulmonary Colonization with Pseudomonas aeruginosa in Cystic Fibrosis Patients

    • Authors: M. Nikolova, Y. Dyankova, I. Hristov, M. Georgieva

    • Journal: Izvestia Journal of the Union of Scientists-Varna. Medicine and Ecology Series

    • Year: 2019

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Dr. Christian Seebauer | Pharmacology | Best Researcher Award

Senior Consultant at Department of Oral and Maxillofacial Surgery / Plastic surgery, University Medicine Lübeck, Germany

Dr. med. Christian Seebauer, MD, DDS, is a distinguished clinician-scientist with dual qualifications in medicine and dentistry and board certifications in Oral and Maxillofacial Surgery and Oral Surgery. Currently a Senior Consultant at University Medical Center Lübeck, he has held several leadership roles in academic surgery. His research focuses on innovative therapies such as cold atmospheric plasma for cancer, wound healing, and oral diseases. He has authored impactful publications in high-ranking journals, with a strong emphasis on translational and interdisciplinary research. Awarded a summa cum laude for his medical doctorate, he is pursuing a second doctorate in dental medicine and a habilitation. Dr. Seebauer is actively involved in clinical trials, academic teaching, and scientific advising. His work reflects a commitment to advancing patient care through science, collaboration, and clinical excellence, making him a highly suitable candidate for prestigious research recognition such as the Best Researcher Award.

Professional Profile 

Google Scholar
Scopus Profile

Education

Dr. Christian Seebauer’s educational background reflects his exceptional commitment to interdisciplinary medical science. He earned his medical degree from Friedrich-Schiller-University Jena in 2006, graduating with high distinction and obtaining his medical license with a “very good” grade. Driven by an interest in craniofacial care, he pursued a second degree in dentistry at Ernst-Moritz-Arndt-University Greifswald, earning his dental license in 2015, again with top marks. He completed specialist training in Oral and Maxillofacial Surgery (2020) and Oral Surgery (2021), and is on track to receive an additional qualification in Plastic and Aesthetic Surgery by 2025. Academically, he achieved his Doctor of Medicine (summa cum laude) from Charité – Berlin in 2012, is completing a second doctorate in dental medicine, and is preparing his habilitation at University Medical Center Lübeck. His dual training uniquely equips him for complex surgical, academic, and translational roles in modern healthcare.

Professional Experience

Dr. Seebauer has accumulated extensive clinical and academic experience in leading German medical institutions. He began his residency in musculoskeletal surgery at Charité – Berlin (2007–2010), then transitioned into Oral and Maxillofacial Surgery at University Medical Centers in Jena and Greifswald. At Greifswald, he steadily advanced from resident to Specialist, then Senior Consultant, and eventually Managing Senior Consultant by 2023. In August 2024, he was appointed Senior Consultant at the University Medical Center Lübeck. Throughout his career, he has taken on multiple responsibilities beyond patient care, including roles in transfusion medicine, radiation safety, and medical coding. Dr. Seebauer is experienced in running clinical trials, mentoring young surgeons, and integrating advanced surgical techniques such as microvascular tissue transfer and plasma-based therapies. His professional trajectory demonstrates continuous growth in clinical leadership, academic excellence, and institutional trust, confirming his status as a respected authority in surgical and translational medicine.

Research Interest

Dr. Seebauer’s research centers on innovative, translational approaches to oral, mucosal, and dermal disease management, with a particular emphasis on cold atmospheric plasma. His work spans a range of high-impact medical themes, including wound healing, cancer therapy, precancerous lesions, chronic inflammation, and alternative cancer treatments. He has contributed significantly to both preclinical and clinical investigations, exploring how plasma technologies can improve outcomes in head and neck cancer, oral lichen planus, and leukoplakia. His recent studies include cohort analyses on the effects of anticoagulants on wound healing and the global impact of HPV vaccination on malignancy risks. He is actively involved in the planning of prospective, multicenter clinical trials and collaborates internationally via networks like TriNetX. His multidisciplinary approach combines surgery, oncology, immunology, and biomedical engineering, showcasing his ability to merge clinical insight with experimental innovation. These interests place him at the forefront of translational medical research in Europe.

Award and Honor

Dr. Christian Seebauer has earned several distinctions throughout his academic and clinical career. He was awarded his Doctor of Medicine degree summa cum laude, one of the highest academic honors in Germany, by the prestigious Charité – University Medical Center Berlin. His scientific work has been published in internationally renowned, peer-reviewed journals such as Radiology, Oral Diseases, and Pharmacological Research, some with impact factors exceeding 10. He has held trusted leadership roles, including Managing Senior Consultant, and serves as a Scientific Advisor to neoplas MED. His selection for these positions reflects institutional recognition of his scientific and clinical integrity. Although not explicitly listed, his rising trajectory in academic medicine and involvement in high-level research projects suggest a strong reputation within professional circles. His affiliations with organizations such as the National Center for Plasma Medicine and Rotary Club also highlight his commitment to service and excellence beyond his clinical duties.

Conclusion

Dr. Christian Seebauer exemplifies the ideal candidate for recognition as a Best Researcher. With dual qualifications in medicine and dentistry, a track record of clinical leadership, and a deep commitment to translational research, he bridges the gap between scientific discovery and patient care. His pioneering work in cold atmospheric plasma and its applications in oncology and regenerative medicine is both innovative and impactful, reflecting future-forward thinking in clinical science. His publication record, leadership roles, and collaborative involvement in global research initiatives further establish his credibility and influence in the medical community. Dr. Seebauer’s academic path—marked by excellence, versatility, and continual advancement—underscores his dedication to improving healthcare through research, education, and clinical innovation. As he continues his habilitation and leads new clinical trials, his contributions are poised to shape future standards in surgery and therapeutic technology. He is highly deserving of prestigious accolades such as the Best Researcher Award.

Publications Top Notes

  • Title: Clinical experience with cold plasma in the treatment of locally advanced head and neck cancer

    • Authors: HR Metelmann, C Seebauer, V Miller, A Fridman, G Bauer, DB Graves, …

    • Year: 2018

    • Citations: 353

  • Title: Head and neck cancer treatment and physical plasma

    • Authors: HR Metelmann, DS Nedrelow, C Seebauer, M Schuster, T von Woedtke, …

    • Year: 2015

    • Citations: 256

  • Title: Molecular mechanisms of the efficacy of cold atmospheric pressure plasma (CAP) in cancer treatment

    • Authors: ML Semmler, S Bekeschus, M Schäfer, T Bernhardt, T Fischer, K Witzke, …

    • Year: 2020

    • Citations: 216

  • Title: Comprehensive clinical plasma medicine: cold physical plasma for medical application

    • Authors: HR Metelmann, T Von Woedtke, KD Weltmann

    • Year: 2018

    • Citations: 162

  • Title: Visible tumor surface response to physical plasma and apoptotic cell kill in head and neck cancer

    • Authors: M Schuster, C Seebauer, R Rutkowski, A Hauschild, F Podmelle, …

    • Year: 2016

    • Citations: 152

  • Title: Cold atmospheric pressure plasma in wound healing and cancer treatment

    • Authors: L Boeckmann, M Schäfer, T Bernhardt, ML Semmler, O Jung, G Ojak, …

    • Year: 2020

    • Citations: 100

  • Title: Treating cancer with cold physical plasma: On the way to evidence‐based medicine

    • Authors: HR Metelmann, C Seebauer, R Rutkowski, M Schuster, S Bekeschus, …

    • Year: 2018

    • Citations: 65

  • Title: Hyperspectral imaging for in vivo monitoring of cold atmospheric plasma effects on microcirculation in treatment of head and neck cancer and wound healing

    • Authors: R Rutkowski, M Schuster, J Unger, C Seebauer, HR Metelmann, …

    • Year: 2017

    • Citations: 58

  • Title: Ankle laxity: stress investigation under MRI control

    • Authors: CJ Seebauer, HJ Bail, JC Rump, B Hamm, T Walter, UKM Teichgräber

    • Year: 2013

    • Citations: 55

  • Title: Side effects in cold plasma treatment of advanced oral cancer—Clinical data and biological interpretation

    • Authors: M Schuster, R Rutkowski, A Hauschild, RK Shojaei, T von Woedtke, …

    • Year: 2018

    • Citations: 48

  • Title: Physical plasma and leukocytes–immune or reactive?

    • Authors: S Bekeschus, C Seebauer, K Wende, A Schmidt

    • Year: 2018

    • Citations: 42

  • Title: Plasmamedizin

    • Authors: HR Metelmann, T von Woedtke, KD Weltmann

    • Year: 2016

    • Citations: 42

  • Title: Cold argon plasma as adjuvant tumour therapy on progressive head and neck cancer: A preclinical study

    • Authors: S Hasse, C Seebauer, K Wende, A Schmidt, HR Metelmann, …

    • Year: 2019

    • Citations: 41

  • Title: Third molars and periodontal damage of second molars in the general population

    • Authors: S Kindler, B Holtfreter, T Koppe, M Mksoud, C Lucas, C Seebauer, …

    • Year: 2018

    • Citations: 36

  • Title: Plasma-derived reactive species shape a differentiation profile in human monocytes

    • Authors: E Freund, J Moritz, M Stope, C Seebauer, A Schmidt, S Bekeschus

    • Year: 2019

    • Citations: 34